sglt2 inhibitors vs glp-1 agonists Comparative effectiveness of inhibitors, receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records Meta-analysis: SGLT2 inhibitors and GLP-1RAs
Pay in 4 interest-free payments of $6.05 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15

























